Pharmacokinetic Genes Do Not Influence Response or Tolerance to Citalopram in the STARD Sample - Peters, Eric J.; Slager, Susan L.; Kraft, Jeffrey B.; Jenkins, Greg D.; Reinalda, Megan S.; McGrath, Patrick J.; Hamilton, Steven P. (PloS one, 2008)
Keywords: Antidepressants; Care and treatment; Case-Control Studies; Citalopram; Citalopram - pharmacokinetics; Clinical Trials as Topic; CYP2D6 protein; Cytochrome; Cytochrome P-450; Cytochrome P-450 Enzyme System - genetics; Cytochrome P450; Deoxyribonucleic acid; Depression (Mood disorder); Depression - drug therapy; DNA; Drug dosages; Drug Resistance - genetics; Drug therapy; Drug Tolerance - genetics; Enzymes; Ethnicity; Female; Gene polymorphism; Genes; Genetic aspects; Genetic polymorphisms; Genetic Predisposition to Disease; Genetic research; Genetic testing; Genetics; Genetics and Genomics/Pharmacogenomics; Genotype; Genotype & phenotype; Health sciences; Humans; Male; Mental depression; Mental Health/Mood Disorders; Mental Health/Psychopharmacology; Metabolism; Metabolites; Mutation; Pharmacokinetics; Pharmacology; Plasma; Polymorphism; Polymorphism, Genetic; Psychiatry; Psychopharmacology; Remission Induction; Selective Serotonin Reuptake Inhibitors - pharmacokinetics; Serotonin; Serotonin uptake inhibitors; Statistical analysis; Studies; New York; San Francisco California; Minnesota; California; United States--US